SARS-CoV-2 infection of human lung epithelial cells induces TMPRSS-mediated acute fibrin deposition
Open Access
- 11 October 2023
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-15
Abstract
Severe COVID-associated lung injury is a major confounding factor of hospitalizations and death with no effective treatments. Here, we describe a non-classical fibrin clotting mechanism mediated by SARS-CoV-2 infected primary lung but not other susceptible epithelial cells. This infection-induced fibrin formation is observed in all variants of SARS-CoV-2 infections, and requires thrombin but is independent of tissue factor and other classical plasma coagulation factors. While prothrombin and fibrinogen levels are elevated in acute COVID BALF samples, fibrin clotting occurs only with the presence of viral infected but not uninfected lung epithelial cells. We suggest a viral-induced coagulation mechanism, in which prothrombin is activated by infection-induced transmembrane serine proteases, such as ST14 and TMPRSS11D, on NHBE cells. Our finding reveals the inefficiency of current plasma targeted anticoagulation therapy and suggests the need to develop a viral-induced ARDS animal model for treating respiratory airways with thrombin inhibitors.Keywords
Funding Information
- Division of Intramural Research (AI001263)
This publication has 77 references indexed in Scilit:
- Fibrin Clots Are Equilibrium Polymers That Can Be Remodeled Without Proteolytic DigestionScientific Reports, 2012
- Tissue Factor, Blood Coagulation, and Beyond: An OverviewInternational Journal of Inflammation, 2011
- Autopsy Findings in Eight Patients With Fatal H1N1 InfluenzaAmerican Journal of Clinical Pathology, 2010
- Venous thromboembolism in patients with acute leukemia, lymphoma, and multiple myelomaThrombosis Research, 2010
- Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patientsCancer, 2007
- In vitro fibrin clot formation and fibrinolysis using heterozygous plasma fibrinogen from γAsn319, Asp320 deletion dysfibrinogen, Otsu IThrombosis Research, 2006
- Fibrinogen and fibrin structure and functionsJournal of Thrombosis and Haemostasis, 2005
- Fibrin Clot Formation and Lysis: Basic MechanismsSeminars in Thrombosis and Hemostasis, 2000
- Cloning and Characterization of the cDNA for Human Airway Trypsin-like ProteaseJournal of Biological Chemistry, 1998
- Severely Impaired Polymerization of Recombinant Fibrinogen γ-364 Asp → His, the Substitution Discovered in a Heterozygous IndividualJournal of Biological Chemistry, 1997